As of December 31, 2021, we had 337.4 million shares of
Class A common shares outstanding, total indebtedness of
$3.9 billion, and cash and cash equivalents of
$48 million.
This Current Report on Form
8-K
contains “forward-looking statements.” These forward-looking
statements relate to beliefs, expectations or intentions and
similar statements concerning matters that are not of historical
fact and are generally accompanied by words such as “estimate,”
“project,” “predict,” “believe,” “expect,” “anticipate,” “intend,”
“potential,” “plan,” “goal,” “outlook,” “guidance” or other words
that convey the uncertainty of future events or outcomes. The
Company has based these forward-looking statements on its current
expectations and assumptions about future events. While the
Company’s management considers these expectations to be reasonable,
they are inherently subject to risks, contingencies and
uncertainties, most of which are difficult to predict and many of
which are beyond the Company’s control and could cause actual
results to differ materially from any future results, performance
or achievements expressed or implied by these forward-looking
statements. Investors should not place undue reliance on these
forward-looking statements, which speak only as of the date of this
Current Report on Form
8-K.
The Company undertakes no obligation to update any forward-looking
statements to conform to actual results or changes in its
expectations, unless required by applicable law. Currently, one of
the most significant factors that could cause actual outcomes to
differ materially from our forward-looking statements is the
adverse effect of the
COVID-19
pandemic. The extent to which
COVID-19
will impact our future financial results will depend on future
developments, which are highly uncertain and cannot be predicted
with confidence, including the scope, severity and duration of the
pandemic, including resurgences, new variants or strains, such as
the Delta or Omicron variant, the impact of government regulations,
vaccine adoption rates (including boosters), the effectiveness of
vaccines, employee retention issues resulting from vaccine
mandates, and the direct and indirect economic effects of the
pandemic and containment measures, among others. For a further
description of the risks and uncertainties that could cause actual
results to differ from those expressed in these forward-looking
statements, as well as risks relating to the business of the
Company in general, see the “Risk Factors” disclosed in the
Company’s Annual Report on Form
10-K
for the year ended December 31, 2020, and in the Company’s
subsequent filings with the SEC.